Quick facts - 08.12.2017 - Sylvie Ponlot

Approval of innovative cancer drugs

Food and Drug Administration (FDA) Commissioner Scott Gottlieb has submitted a new system to the Congress Committee to accelerate the approval of innovative cancer drugs. Medication that has already been approved and has proved to be of marked efficiency for a new target indication will receive approval from the FDA without going through phase III clinical trials.